AEMD (Aethlon Medical Inc) Rentabilitas dodolan miturut bathi reged

Aethlon Medical (AEMD) success is based on the recognized effectiveness of blood purification from tumor markers and viruses. The gross margin ratio illustrates current operational efficiency, where the value 0.00 represents the latest figure. This enables the integration of Hemopurifier into intensive care protocols, aiming to capture the niche of unique therapeutic filters before similar systems are released by corporate behemoths.
Rincian metrik komprehensif lan analitis Aethlon Medical (AEMD)

Investors use this ratio to determine a business's ability to generate profit before accounting for administrative expenses. The metric is calculated as the ratio of the difference between revenue and cost of goods sold to total sales, reflecting the efficiency of direct cost management. An analysis of the base gross margin confirms the profitability of producing Hemopurifier systems for Aethlon Medical (AEMD), assessing the cost of creating filters for clearing blood of pathogens.